Recombinant Human GALNTL1 (C-6His)

Description

EnkiLife provides the Recombinant Human GALNTL1 (C-6His) protein,aslo know as Putative Polypeptide N-Acetylgalactosaminyltransferase-Like Protein 1,Polypeptide GalNAc Transferase-Like Protein 1,GalNAc-T-Like Protein 1,pp-GaNTase-Like Protein 1,Protein-UDP Acetylgalactosaminyltransferase-Like Protein 1,UDP-GalNAc:Polypeptide N-Acetylgalactosaminyltransferase-Like Protein 1,GALNTL1,KIAA1130, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Putative Polypeptide N-Acetylgalactosaminyltransferase-Like Protein 1 is produced by our Mammalian expression system and the target gene encoding Asp27-Thr558 is expressed with a 6His tag at the C-terminus.Accession:Q8N428. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:61 KDa. Background:Putative polypeptide N-acetylgalactosaminyltransferase-like protein 1, also known as Polypeptide GalNAc transferase-like protein 1, Protein-UDP acetylgalactosaminyltransferase-like protein 1, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1, GalNAC-T-like protein 1, pp-GaNTase-like protein 1 and GALNTL1, belongs to the glycosyltransferase 2 family. GALNTL1 plays an important role in the protein modification and protein glycosylation process. GALNTL1 uses the manganese and calcium ion as a cofactor, may catalyze the initial reaction in O-linked oligosaccharide biosynthesis, transfers the N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor.